ZS partners with Intelligencia as part of $12M push to reduce clinical development risk

Retrieved on: 2021-08-17 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

ZS partners with Intelligencia as part of $12M push to reduce clinical development risk. View article details on hiswai:

Excerpt

ZS will use Intelligencia's artificial intelligence platform to research diseases and pipeline products and to assess regulatory success. (Pixabay).

Article found on: www.fiercebiotech.com